tiprankstipranks
Trending News
More News >
SinoMab Bioscience Ltd. (HK:3681)
:3681
Hong Kong Market

SinoMab Bioscience Ltd. (3681) Income Statement

Compare
0 Followers

SinoMab Bioscience Ltd. Income Statement

Last quarter (Q4 2024), SinoMab Bioscience Ltd.'s total revenue was ¥-4.05M, an increase of 18.39% from the same quarter last year. In Q4, SinoMab Bioscience Ltd.'s net income was ¥-94.52M. See SinoMab Bioscience Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 2.03M¥ 1.36M¥ 4.03M¥ 26.66M¥ 12.76M
Gross Profit
¥ 543.00K¥ 422.00K¥ 4.03M¥ 26.66M¥ 12.76M
Operating Expenses
¥ 161.90M¥ 230.00M¥ 292.81M¥ 325.76M¥ 150.29M
Depreciation and Amortization
¥ 19.13M¥ 36.06M¥ 14.63M¥ 20.66M¥ 4.04M
EBITDA
¥ -142.79M¥ -200.46M¥ -244.29M¥ -296.43M¥ -158.61M
Operating Income
¥ -161.35M¥ -229.57M¥ -258.93M¥ -305.86M¥ -162.65M
Other Income/Expenses
¥ -23.79M¥ -13.54M¥ -25.23M¥ 17.66M¥ 40.05M
Pretax Income
¥ -185.14M¥ -243.11M¥ -284.16M¥ -288.19M¥ -122.60M
Net Income
¥ -185.14M¥ -243.11M¥ -284.16M¥ -288.19M¥ -122.60M
Per Share Metrics
Basic EPS
¥ -0.17¥ -0.24¥ -0.29¥ -0.29¥ -0.12
Diluted EPS
¥ -0.17¥ -0.24¥ -0.29¥ -0.29¥ -0.12
Weighted Average Shares Outstanding
1.07B 1.02B 991.96M 994.89M 1.01B
Weighted Average Shares Outstanding (Diluted)
1.07B 1.02B 991.96M 994.89M 1.01B
Currency in CNY

SinoMab Bioscience Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis